Abstract
• Shenqishiyiwei granules (SQSYW) is an approved traditional Chinese medicine formulation used as an adjuvant for cancer patients in China, which includes several medicine food homology herbs. • The multi-level, multi-objective effect of SQSYW is determined by combining the numerous active ingredients of SQSYW. • SQSYW may play essential roles in the treatment of Gastric Cancer (GC) by regulating the proteins that function in the immune system. • The bioactive compounds of SQSYW, including panaxadiol, betulinic acid, alisol B, and stigmasterol, may have anti-cancer effects against GC. Shenqishiyiwei granules (SQSYW) is an approved traditional Chinese medicine formulation used as an adjuvant for cancer patients in China, which includes several medicine food homology herbs. Accumulating studies have reported that SQSYW reduces the side effects of chemotherapy and improves the quality of life of patients with gastric cancer (GC). However, the mechanism of action of SQSYW in GC remains unclear. Here, the pharmacological mechanism of action of SQSYW in GC was investigated. The Traditional Chinese Medicine Systems Pharmacology (TCMSP) database was used to identify 98 active compounds and 241 protein targets of SQSYW, while 3932 GC-related proteins were identified from DisGeNET. The 182 overlapping targets of SQSYW and GC represented the potential therapeutic targets of SQSYW in GC. Gene Ontology (GO) enrichment analysis indicated that the overlapping targets were mostly enriched in the regulation of apoptotic process, programmed cell death, and immune processes. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis indicated that SQSYW could prevent GC via the tumor necrosis factor (TNF) and PI3K-Akt signaling pathways and apoptosis. Molecular docking revealed that sesamin interacted with several proteins involved in immune processes, including IKBKB, TNF superfamily (TNFSF)13B, IL2, PRKCB, and SIRT1. The findings demonstrated that the anti-GC activity of SQSYW could be mediated via the regulation of proteins involved in immune processes, and provides evidence that support the potential therapeutic application of SQSYW in GC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
